Alyabsi Mesnad, Aldibasi Omar, Bosaeed Mohammad, Alanazi Maha, Alqarni Anwar, Albdah Bayan, Alharbi Naif Khalaf, Alghnam Suliman
Population Health Research Section, King Abdullah International Medical Research Center, P.O. Box 22490, Riyadh 11426, Saudi Arabia.
King Saud Bin Abdulaziz University for Health Sciences, P.O. Box 22490, Riyadh 11426, Saudi Arabia.
J Clin Med. 2022 Jul 20;11(14):4199. doi: 10.3390/jcm11144199.
Coronavirus disease 2019 (COVID-19) survivors can have lasting signs and symptoms, including various organ damage, indicating that COVID-19 can be a chronic illness. The current study aims to compare the 30-day hospital readmission and death rate of patients admitted to the hospital with COVID-19 and pneumonia due to other causes. A retrospective cohort study was conducted using data from the Saudi National Guard Health Affairs (NGHA). Records of patients admitted with COVID-19 between 1 March 202 and 31 December 2020 ( = 3597) and pneumonia during 2017 and 2019 ( = 6324) were retrieved and analyzed. We compared the likelihood of 30-day hospital readmission, intensive care unit (ICU) admission, and death between the two groups. Compared with the control group, COVID-19 patients had higher odds of 30-day readmission (odds ratio 1.90, 95% confidence interval 1.61-2.24), higher risk of ICU transfer (hazard ratio 1.85, 95% confidence interval 1.65-2.07), more extended hospital stay (7 vs. 4 days), but less risk of death (hazard ratio 0.18, 95% confidence interval 0.14-0.24). The findings that hospital readmission was higher in COVID-19 recovered patients than in other pneumonia patients inform the current discussion about readmission and death in COVID-19 patients.
2019冠状病毒病(COVID-19)幸存者可能会有持续的体征和症状,包括各种器官损伤,这表明COVID-19可能是一种慢性病。本研究旨在比较因COVID-19住院的患者与因其他原因患肺炎的患者的30天再入院率和死亡率。利用沙特国民卫队卫生事务局(NGHA)的数据进行了一项回顾性队列研究。检索并分析了2020年3月1日至12月31日期间因COVID-19入院的患者(n = 3597)以及2017年至2019年期间因肺炎入院的患者(n = 6324)的记录。我们比较了两组患者30天再入院、重症监护病房(ICU)入院和死亡的可能性。与对照组相比,COVID-19患者30天再入院的几率更高(比值比1.90,95%置信区间1.61-2.24),转入ICU的风险更高(风险比1.85,95%置信区间1.65-2.07),住院时间更长(7天对4天),但死亡风险更低(风险比0.18,95%置信区间0.14-0.24)。COVID-19康复患者的再入院率高于其他肺炎患者这一发现,为当前关于COVID-19患者再入院和死亡的讨论提供了参考。